Liver histology in chronic hepatitis B patients after 1 year of treatment with pegylated interferon alpha-2b in combination with lamivudine or placebo

被引：0
|
作者：
van Zonneveld, M [1 ]
Zondervan, P [1 ]
de Man, RA [1 ]
Schalm, SW [1 ]
Janssen, HLA [1 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF HEPATOLOGY | 2004年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
447
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [21] Efficacy of pegylated interferon alpha-2b in combination with ribavirin in patients with chronic hepatitis C non-responders to a previous treatment
    Chousterman, M
    Auray-Cartier, V
    Hagege, H
    Arpurt, JP
    Cassan, P
    Denis, J
    Gargot, D
    Nalet, B
    Nouel, O
    Pariente, A
    Wartelle-Bladou, C
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 133 - 134
  • [22] Pegylated interferon alpha-2a (Pegasys) versus pegylated interferon alpha-2b (Pegintron) in the treatment of chronic hepatitis C infection
    Anees, MR
    Reddymasu, S
    Bejjanki, HR
    Caldito, G
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S142 - S142
  • [23] Combination of pegylated interferon and lamivudine is superior to lamivudine monotherapy in the treatment of chronic hepatitis B - A randomized trial
    Sung, JJY
    Chan, HLY
    Hui, A
    Chan, FKL
    Chim, AML
    Wong, ML
    Leung, NWY
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 : 33 - 33
  • [24] Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment previously
    Hissar, S. S.
    Kumar, M.
    Sharma, B. C.
    Sarin, S. K.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S96 - S97
  • [25] Treatment of acute hepatitis C with pegylated interferon alpha-2b and ribavirin
    Capozza, TA
    Brann, OS
    Coyle, WJ
    Schindler, WR
    BeMiller, TA
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S188 - S188
  • [26] Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotheraphy in patients with chronic hepatitis B, a multicenter, randomized trial
    Barbaro, G
    Zechini, F
    Pellicelli, AM
    Francavilla, R
    Scotto, G
    Bacca, D
    Bruno, M
    Babudieri, S
    Annese, M
    Matarazzo, F
    Di Stefano, G
    Starnini, G
    Zocchetti, C
    Barbarini, G
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 136 - 136
  • [27] Relapse in HBeAg-positive chronic hepatitis B after peg-interferon alpha-2b therapy alone or in combination with lamivudine
    Flink, HJ
    Hansen, BE
    de Man, RA
    Schalm, SW
    Janssen, HL
    [J]. HEPATOLOGY, 2005, 42 (04) : 588A - 588A
  • [28] TREATMENT OF CHRONIC HEPATITIS-B WITH RECOMBINANT ALPHA-2B INTERFERON
    MULLER, R
    BAUMGARTEN, R
    MARKUS, R
    SCHULZ, M
    WITTENBERG, H
    HINTSCHEKILGER, B
    FENGLER, JD
    VONWUSSOW, P
    MEISEL, H
    KLEIN, H
    MALMUS, K
    SCHMIDT, FW
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1990, 115 (11) : 403 - 407
  • [29] Improvement of liver histology after one year of lamivudine therapy in patients with chronic hepatitis B
    Jin, RH
    Lang, ZW
    Yao, GB
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A762 - A762
  • [30] HBV viral dynamics during treatment of naive patients with HBeAg(-) chronic hepatitis B with pegylated interferon alpha 2b alone or in combination with lamivudine
    Sypsa, V
    Mimidis, K
    Tassopoulos, NC
    Chrysagis, D
    Vassiliadis, T
    Moulakakis, A
    Raptopoulou, M
    Haida, C
    Hatzakis, A
    [J]. HEPATOLOGY, 2004, 40 (04) : 668A - 669A
12345